Neoadjuvant cisplatin and paclitaxel modulate tumor-infiltrating T cells in patients with cervical cancer

Author(s):
Heeren, A.M.; Luijk, I.F. van; Lakeman, J.; Pocorni, N.; Kole, J.; Menezes, R.X. de; Kenter, G.M.G.; Bosse, T.; Kroon, C.D. de; Jordanova, E.S. (0000-0002-8121-1322)
Published
2019
Publication type
Article / Letter to editor
Cervical cancerNeoadjuvant chemotherapyCisplatinPaclitaxelTumor microenvironmentT cells
Date issued
2019-11-30
Language
English
Is part of
Cancer Immunology, Immunotherapy (2019), Vol. 68, no. 11, p. 1759-1767
hdl
1887/121022
doi
10.1007/s00262-019-02412-x